Top compounds associated with response to RP11-977G19.10


Feature Type Standardized
Nominal ANOVA
mRNA nelarabine CTRPv2 pan-cancer AAC -0.12 0.003
mRNA canertinib CTRPv2 pan-cancer AAC -0.11 0.004
mRNA AA-COCF3 CTRPv2 pan-cancer AAC -0.1 0.004
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.004
mRNA AZD0530 CTRPv2 pan-cancer AAC -0.1 0.005
mRNA CHEMBL1222381 CTRPv2 pan-cancer AAC 0.094 0.005
mRNA PL-DI CTRPv2 pan-cancer AAC -0.089 0.005
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.006
mRNA pluripotin CTRPv2 pan-cancer AAC -0.095 0.008
mRNA avrainvillamide CTRPv2 pan-cancer AAC -0.11 0.009
Download CSV